References
- Arana, G. W., Baldessarini, R. J., & Ornsteen, M. (1985). The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Archives of General Psychiatry, 42(12), 1193–1204. doi:10.1001/archpsyc.1985.01790350067012
- American Psychiatric Association (APA). (1980/2013). Diagnostic and statistical manual of mental disorders. Arlington, VA: American Psychiatric Press.
- Armitage, R. (2007). Sleep and circadian rhythms in mood disorders. Acta Psychiatrica Scandinavica, 115(s433), 104–115. doi:10.1111/j.1600-0447.2007.00968.x
- Baglioni, C., Nanovska, S., Regen, W., Spiegelhalder, K., Feige, B., Nissen, C., … Riemann, D. (2016). Sleep and mental disorders: Meta-analysis of polysomnographic research. Psychological Bulletin, 142(9), 969–990. doi:10.1037/bul0000053
- Baldessarini, R. J. (2013). Chemotherapy in psychiatry (3rd ed.). New York: Springer Press.
- Brown, W. A. (2007). Treatment response in melancholia. Acta Psychiatrica Scandinavica, 115(s433), 125–135. doi:10.1111/j.1600-0447.2007.00970.x
- Carroll, B. J. (1985). Dexamethasone suppression test: Review of contemporary confusion. The Journal of Clinical Psychiatry, 46(2 Pt 2), 13–24.
- Centorrino, F., Fogarty, K. V., Sani, G., Salvatore, P., Cimbolli, P., & Baldessarini, R. J. (2005). Antipsychotic drug use: McLean Hospital, 2002. Human Psychopharmacology: Clinical and Experimental, 20(5), 355–358. doi:10.1002/hup.700
- Christiaens, F., & Maes, M. (1994). TRH-test in depression: A review. Acta Neuropsychiatrica, 4(4), 71–76. doi:10.1017/S0924270800034116
- Fairchild, C. J., Rush, A.J., Vasavada, N., Giles, D. E., & Khatami, M. (1986). Which depressions respond to placebo? Psychiatry Research, 18(3), 217–226. doi:10.1016/0165-1781(86)90109-5
- Fuchs, T. (2013). Temporality and psychopathology. Phenomenology and the Cognitive Sciences, 12(1), 75–104. doi:10.1007/s11097-010-9189-4
- Gitlin, M. J., & Gerner, R. H. (1986). The dexamethasone suppression test and response to somatic treatment: A review. Journal of Clinical Psychiatry, 47(1), 16–21.
- Koukopoulos, A., & Sani, G. (2014). DSM-5 criteria for depression with mixed features: A farewell to mixed depression. Acta Psychiatrica Scandinavica, 129(1), 4–16. doi:10.1111/acps.12140
- Koukopoulos, A., Sani, G., Koukopoulos, A. E., Manfredi, G., Pacchiarotti, I., & Girardi, P. (2007). Melancholia agitata and mixed depression. Acta Psychiatrica Scandinavica, 115(433), 50–57. doi:10.1111/j.1600-0447.2007.00963.x
- Myers, E. D. (1988). Predicting the response of depressed patients to biological treatment: Dexamethasone suppression test vs. clinical judgment. British Journal of Psychiatry, 152(5), 657–659. doi:10.1192/bjp.152.5.657
- Parker, G. (2000). Classifying depression: Should paradigms lost be regained? American Journal of Psychiatry, 157(8), 1195–1203. doi:10.1176/appi.ajp.157.8.1195
- Parker, G., Fink, M., Shorter, E., Taylor, M. A., Akiskal, H., Berrios, G., … Swartz, C. (2010). Issues for DSM-5: Whither melancholia? The case for its classification as a distinct mood disorder. American Journal of Psychiatry, 167(7), 745–747. doi:10.1176/appi.ajp.2010.09101525
- Parker, G., McClure, G., & Paterson, A. (2015). Melancholia and catatonia: Disorders or specifiers? Current Psychiatry Reports, 17(1), 536–341. doi:10.1007/s11920-014-0536-y
- Parker, G., & McCraw, S. (2017). The properties and utility of the CORE measure of melancholia. Journal of Affective Disorders, 207(1), 128–135. doi:10.1016/j.jad.2016.09.029
- Paykel, E. S. (2008). Basic concepts of depression. Dialogues in Clinical Neuroscience, 10(3), 279–289.
- Perry, P. J. (1996). Pharmacotherapy for major depression with melancholic features: Relative efficacy of tricyclic vs. serotonin reuptake inhibitor antidepressants. Journal of Affective Disorders, 39(1), 1–6. doi:10.1016/0165-0327(96)00014-6
- Peselow, E. D., Sanfilipo, M. P., Difiglia, C., & Fieve, R. R. (1992). Melancholic/endogenous depression and response to somatic treatment and placebo. American Journal of Psychiatry, 149(10), 1324–1334. doi:10.1176/ajp.149.10.1324
- Quitkin, F. M., Stewart, J. W., McGrath, P. J., Tricamo, E., Rabkin, J. G., Ocepek-Welikson, K., … Klein, D. F. (1993). Columbia atypical depression: A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. British Journal of Psychiatry, 163(S21), 30–34. doi:10.1192/S0007125000292465
- Rush, A., Giles, D. E., Schlesser, M. A., Orsulak, P. R., Weissenburger, J. E., Fulton, C. L., … Roffwarg, H. P. (1997). Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye-movement latency, and subtypes of depression. Biological Psychiatry, 41(9), 915–928. doi:10.1016/S0006-3223(97)00148-0
- Salvatore, P., Indic, P., Murray, G., & Baldessarini, R. J. (2012). Biological rhythms and mood disorders. Dialogues in Clinical Neuroscience, 14(4), 369–379.
- Sani, G., & Swann, A. C. (2020). Mixed states: Historical impact and evolution of the concept. Psychiatric Clinics of North America, 43(1), 1–13. doi:10.1016/j.psc.2019.10.001
- Shorter, E. (1997). A history of psychiatry. New York: John Wiley.
- Showraki, M. (2019). Reactive depression: Lost in translation. The Journal of Nervous and Mental Disease, 207(9), 755–759. doi:10.1097/NMD.0000000000000989
- Taylor, M. A., & Fink, M. (2006). Melancholia. New York: Cambridge University Press.
- Tondo, L., Abramowicz, M., Alda, M., Bauer, M., Bocchetta, A., Bolzani, L., … Baldessarini, R. J. (2017). Long-term lithium treatment in bipolar disorder: Effects on glomerular filtration rate and other metabolic parameters. International Journal of Bipolar Disorders, 5(1), 27. doi:10.1186/s40345-017-0096-2
- Tondo, L., Vázquez, G. H., & Baldessarini, R. J. (2019). Melancholic vs. nonmelancholic. Journal of Affective Disorders. Advance online publication. doi:10.1016/j.jad.2020.01.139
- Tondo, L., Vázquez, G. H., Pinna, M., Vaccotto, P. A., & Baldessarini, R. J. (2018). Characteristics of depressive and bipolar patients with mixed features. Acta Psychiatrica Scandinavica, 138(3), 243–252. doi:10.1111/acps.12911
- Trede, K., Salvatore, P., Baethge, C., Gerhard, A., Maggini, C., & Baldessarini, R. J. (2005). Manic-depressive illness: Evolution in Kraepelin’s Textbook, 1883–1926. Harvard Review of Psychiatry, 13(3), 155–178. doi:10.1080/10673220500174833
- Undurraga, J. P., Vázquez, G. H., & Baldessarini, R. J. (2019). Treatment responses in melancholic and nonmelancholic depression. The Journal of Psychopharmacology.
- WHO (World Health Organization). (1992). InternationaI classification of diseases, tenth revision (ICD-10). Geneva: WHO.
- Wijkstra, J., Lijmer, J., Balk, F. J., Geddes, R. J., & Nolen, W. A. (2006). Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis. British Journal of Psychiatry, 188(5), 410–415. doi:10.1192/bjp.bp.105.010470
- Zimmerman, M. (2019). Severity and treatment of depression: Review of two controversies. The Journal of Nervous and Mental Disease, 207(4), 219–223. doi:10.1097/NMD.0000000000000960